المصدر: Efficacy and Safety of Rasburicase in the Treatment of Chronic Gouty Arthritis: A Multicenter Randomized Controlled Study

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05312268Test

المصدر: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05226013Test

المؤلفون: BDD Pharma Ltd

المصدر: A Phase 1, Single Centre, Two-Part, Open Label, Crossover Study in Healthy Volunteers Using Scintigraphy to Characterize the In Vivo Performance of ALLN-346 Enteric Coated Tablets

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05168683Test

المصدر: A Randomized, Double-Blind, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects With Gout and Mild to Moderate Chronic Kidney Disease

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04987294Test

المصدر: An Inpatient, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04987242Test

المصدر: A Phase I Randomized, Double-Blind, Placebo Controlled, Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04829435Test

المصدر: Effect of Pegloticase on Reduction of Uric Acid in Patients With Tumor Lysis Syndrome: A Pilot Pragmatic Clinical Trial

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04745910Test

Other URLs: http://www.mdanderson.orgTest

المصدر: An Open-label, Single-arm, Multi-center Study to Evaluate the Efficacy and Safety of Rasburicase (Fasturtec) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin¿s Lymphoma and Acute Leukemia

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04349306Test

المصدر: A Phase I Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04236219Test

المصدر: An Open Label, Single-dose, Dose-increasing Study to Assess the Safety, Tolerability, PK and Preliminary PD of PEGylated Recombinant Candida Urate Oxidase (SSS11) for Injection in Chinese Healthy Adult Volunteers

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04047394Test